BCG Vaccine Market By Drug Type, Usage and Application - Global Industry Analysis & Forecast to 2027
Published On : June 2022 Pages : 195 Category: Pharmaceuticals Report Code : HC0617301
The global BCG Vaccine Market is valued at USD XX million in 2021 and is projected to reach USD XX million by the end of 2027, growing at a CAGR of XX% during the period 2022 to 2027.
Industry Outlook and Trend Analysis
BCG Vaccine is a vaccine essentially useful against tuberculosis. Tuberculosis is a severe infection, which damages the lungs and at times different parts of the body, for example, the joints, kidneys and bones. The bacille Calmette-Guérin (BCG) vaccine has existed for a long time and is a standout amongst the most broadly used of all conventional vaccines. The factors that drive the worldwide BCG vaccine market incorporate increment in prevalence of tuberculosis, particularly in creating and immature nations, and mechanical progression in the section of vaccine research. In addition, the expansion in government activities and spotlight on vaccination programs all around additionally help the market development. Nonetheless, symptoms of BCG vaccine and a worldwide lack of this immunization hinder the development of the market.
Type Outlook and Trend Analysis
Based on type the market is segmented into Therapy BCG and Immune BCG. Immune Intravesical Bacillus Calmette-Guerin (Immune BCG) is a debilitated nonpathogenic strain of Mycobacterium bovis that was first used as an antibody agent against tuberculosis. This vaccine permits achieving inertia stage by methods for control of the bacillus by serial advancement on culture medium. Therapy BCG vaccines upgrades Th1 immune responses in people. In cases as such, Th1 and Th2 cells are similarly coordinated. Treatment BCG inoculation are basically extended and compelled to the expiratory volume in 1 second and are additionally obliged to expiratory stream rate of around 25% to 75% at weeks 4, 8, and 12. In addition, treatment BCG vaccination is known for upgraded lung work and diminished pharmaceutical use in adults with direct to-serious asthma.
Application Outlook and Trend Analysis
Based on application the market is segmented into Clinics and Hospitals. Clinics play an essential part in spreading and vaccinating infants and children with BCG vaccines. For example, Tuberculosis is a basic general prosperity challenge in universally. In hospitals, the BCG vaccination is usually given to kids as it has been seemed to give extraordinary affirmation against the scattered kinds of TB in youths, including TB meningitis. However the affirmation gave against pneumonic TB in adults is to a great degree a main factor.
Regional Outlook and Trend Analysis
Geographically, the market is segmented into North America, Asia Pacific, Europe and Rest of the world. Europe is the dominating region of the BCG vaccines market. Asia Pacific is foreseen to develop significantly in the upcoming years.
Competitive Insights
The leading players in the market are Microgen, InterVax Ltd, Merck Sharp & Dohme Corp., Green Signal Bio Pharma Private Limited, Japan BCG Laboratory, AJ Vaccines, Sanofi S.A., Serum Institute of India Pvt Ltd and Biomed Lublin S.A. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
This report forecasts revenue growth at global, regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2017 to 2027. This report has segmented the BCG Vaccine Market on the basis of fabric, product, application, and region:
By Region
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Mexico
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- South Africa
- Turkey
- Rest of MEA
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2022 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· BCG Vaccine Market, By Drug Type, Estimates and Forecast, 2017-2027 ($Million)
o Immune BCG
o Therapy BCG
· BCG Vaccine Market, By Usage, Estimates and Forecast, 2017-2027 ($Million)
o Tuberculosis
o Bladder Cancer
· BCG Vaccine Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Clinics
o Hospitals
o Others
· BCG Vaccine Market, By Key Players
o Microgen
o InterVax Ltd
o Merck Sharp & Dohme Corp.
o Green Signal Bio Pharma Private Limited
o Japan BCG Laboratory
o Serum Institute of India Pvt Ltd
o AJ Vaccines
o Biomed Lublin S.A.
o Sanofi S.A.
· BCG Vaccine Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America BCG Vaccine Market, By Country
o U.S. BCG Vaccine Market
o Canada BCG Vaccine Market
o Europe
§ Europe BCG Vaccine Market, By Country
o UK BCG Vaccine Market
o Germany BCG Vaccine Market
o France BCG Vaccine Market
o Russia BCG Vaccine Market
o Italy BCG Vaccine Market
o Rest of Europe BCG Vaccine Market
o Asia-Pacific
§ Asia-Pacific BCG Vaccine Market, By Country
o China BCG Vaccine Market
o Japan BCG Vaccine Market
o South Korea BCG Vaccine Market
o India BCG Vaccine Market
o Southeast Asia BCG Vaccine Market
o Rest of Asia-Pacific BCG Vaccine Market
o South America
§ South America BCG Vaccine Market
o Brazil BCG Vaccine Market
o Mexico BCG Vaccine Market
o Columbia BCG Vaccine Market
o Rest of South America BCG Vaccine Market
o Middle East and Africa
§ Middle East and Africa BCG Vaccine Market
o Saudi Arabia BCG Vaccine Market
o UAE BCG Vaccine Market
o South Africa BCG Vaccine Market
o Turkey BCG Vaccine Market
o Rest of MEA BCG Vaccine Market
Table of Contents
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. BCG Vaccine Market, By Drug Type
5.1. Introduction
5.2. Global BCG Vaccine Revenue and Market Share by Drug Type (2017-2021)
5.2.1. Global BCG Vaccine Revenue and Revenue Share by Drug Type (2017-2021)
5.3. Immune BCG
5.3.1. Global Immune BCG Revenue and Growth Rate (2017-2021)
5.4. Therapy BCG
5.4.1. Global Therapy BCG Revenue and Growth Rate (2017-2021)
6. BCG Vaccine Market, By Usage
6.1. Introduction
6.2. Global BCG Vaccine Revenue and Market Share by Usage (2017-2021)
6.2.1. Global BCG Vaccine Revenue and Revenue Share by Usage (2017-2021)
6.3. Tuberculosis
6.3.1. Global Tuberculosis Revenue and Growth Rate (2017-2021)
6.4. Bladder Cancer
6.4.1. Global Bladder Cancer Revenue and Growth Rate (2017-2021)
7. BCG Vaccine Market, By Application
7.1. Introduction
7.2. Global BCG Vaccine Revenue and Market Share by Application (2017-2021)
7.2.1. Global BCG Vaccine Revenue and Revenue Share by Application (2017-2021)
7.3. Clinics
7.3.1. Global Clinics Revenue and Growth Rate (2017-2021)
7.4. Hospitals
7.4.1. Global Hospitals Revenue and Growth Rate (2017-2021)
7.5. Others
7.5.1. Global Others Revenue and Growth Rate (2017-2021)
8. BCG Vaccine Market, By Region
8.1. Introduction
8.2. Global BCG Vaccine Revenue and Market Share by Regions
8.2.1. Global BCG Vaccine Revenue by Regions (2017-2021)
8.3. North America BCG Vaccine by Countries
8.3.1. North America BCG Vaccine Revenue and Growth Rate (2017-2021)
8.3.2. North America BCG Vaccine Revenue (Million USD) by Countries (2017-2021)
8.3.3. United States
8.3.3.1. United States BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
8.3.4. Canada
8.3.4.1. Canada BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
8.3.5. Mexico
8.3.5.1. Mexico BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
8.4. Europe BCG Vaccine by Countries
8.4.1. Europe BCG Vaccine Revenue and Growth Rate (2017-2021)
8.4.2. Europe BCG Vaccine Revenue (Million USD) by Countries (2017-2021)
8.4.3. Germany
8.4.3.1. Germany BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
8.4.4. France
8.4.4.1. France BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
8.4.5. UK
8.4.5.1. UK BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
8.4.6. Russia
8.4.6.1. Russia BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
8.4.7. Italy
8.4.7.1. Italy BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
8.4.8. Rest of Europe
8.4.8.1. Rest of Europe BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
8.5. Asia-Pacific BCG Vaccine by Countries
8.5.1. Asia-Pacific BCG Vaccine Revenue and Growth Rate (2017-2021)
8.5.2. Asia-Pacific BCG Vaccine Revenue (Million USD) by Countries (2017-2021)
8.5.3. China
8.5.3.1. China BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
8.5.4. Japan
8.5.4.1. Japan BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
8.5.5. Korea
8.5.5.1. Korea BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
8.5.6. India
8.5.6.1. India BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
8.5.7. Southeast Asia
8.5.7.1. Southeast Asia BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
8.5.8. Rest of Asia-Pacific
8.5.8.1. Rest of Asia-Pacific BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
8.6. South America BCG Vaccine by Countries
8.6.1. South America BCG Vaccine Revenue and Growth Rate (2017-2021)
8.6.2. South America BCG Vaccine Revenue (Million USD) by Countries (2017-2021)
8.6.3. Brazil
8.6.3.1. Brazil BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
8.6.4. Argentina
8.6.4.1. Argentina BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
8.6.5. Columbia
8.6.5.1. Columbia BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
8.6.6. Rest of South America
8.6.6.1. Rest of South America BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
8.7. Middle East and Africa BCG Vaccine by Countries
8.7.1. Middle East and Africa BCG Vaccine Revenue and Growth Rate (2017-2021)
8.7.2. Middle East and Africa BCG Vaccine Revenue (Million USD) by Countries (2017-2021)
8.7.3. Saudi Arabia
8.7.3.1. Saudi Arabia BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
8.7.4. United Arab Emirates
8.7.4.1. United Arab Emirates BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
8.7.5. Egypt
8.7.5.1. Egypt BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
8.7.6. Nigeria
8.7.6.1. Nigeria BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
8.7.7. South Africa
8.7.7.1. South Africa BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
8.7.8. Turkey
8.7.8.1. Turkey BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
9. Company Profiles
9.1. Microgen
9.1.1. Business Overview
9.1.2. Service Portfolio
9.1.3. Strategic Developments
9.1.4. Financial Overview
9.2. InterVax Ltd
9.2.1. Business Overview
9.2.2. Service Portfolio
9.2.3. Strategic Developments
9.2.4. Financial Overview
9.3. Merck Sharp & Dohme Corp.
9.3.1. Business Overview
9.3.2. Service Portfolio
9.3.3. Strategic Developments
9.3.4. Financial Overview
9.4. Green Signal Bio Pharma Private Limited
9.4.1. Business Overview
9.4.2. Service Portfolio
9.4.3. Strategic Developments
9.4.4. Financial Overview
9.5. Japan BCG Laboratory
9.5.1. Business Overview
9.5.2. Service Portfolio
9.5.3. Strategic Developments
9.5.4. Financial Overview
9.6. Serum Institute of India Pvt Ltd
9.6.1. Business Overview
9.6.2. Service Portfolio
9.6.3. Strategic Developments
9.6.4. Financial Overview
9.7. AJ Vaccines
9.7.1. Business Overview
9.7.2. Service Portfolio
9.7.3. Strategic Developments
9.7.4. Financial Overview
9.8. Biomed Lublin S.A.
9.8.1. Business Overview
9.8.2. Service Portfolio
9.8.3. Strategic Developments
9.8.4. Financial Overview
9.9. Sanofi S.A.
9.9.1. Business Overview
9.9.2. Service Portfolio
9.9.3. Strategic Developments
9.9.4. Financial Overview
10. BCG Vaccine Market Forecast (2022-2027)
10.1. Global BCG Vaccine Revenue (Millions USD) and Growth Rate (2022-2027)
10.2. BCG Vaccine Market Forecast by Regions (2022-2027)
10.2.1. North America BCG Vaccine Market Forecast (2022-2027)
10.2.1.1. United States BCG Vaccine Market Forecast (2022-2027)
10.2.1.2. Canada BCG Vaccine Market Forecast (2022-2027)
10.2.1.3. Mexico BCG Vaccine Market Forecast (2022-2027)
10.2.2. Europe BCG Vaccine Market Forecast (2022-2027)
10.2.2.1. Germany BCG Vaccine Market Forecast (2022-2027)
10.2.2.2. France BCG Vaccine Market Forecast (2022-2027)
10.2.2.3. UK BCG Vaccine Market Forecast (2022-2027)
10.2.2.4. Russia BCG Vaccine Market Forecast (2022-2027)
10.2.2.5. Italy BCG Vaccine Market Forecast (2022-2027)
10.2.2.6. Rest of Europe BCG Vaccine Market Forecast (2022-2027)
10.2.3. Asia-Pacific BCG Vaccine Market Forecast (2022-2027)
10.2.3.1. China BCG Vaccine Market Forecast (2022-2027)
10.2.3.2. Japan BCG Vaccine Market Forecast (2022-2027)
10.2.3.3. Korea BCG Vaccine Market Forecast (2022-2027)
10.2.3.4. India BCG Vaccine Market Forecast (2022-2027)
10.2.3.5. Southeast Asia BCG Vaccine Market Forecast (2022-2027)
10.2.3.6. Rest of Asia-Pacific BCG Vaccine Market Forecast (2022-2027)
10.2.4. South America BCG Vaccine Market Forecast (2022-2027)
10.2.4.1. Brazil BCG Vaccine Market Forecast (2022-2027)
10.2.4.2. Argentina BCG Vaccine Market Forecast (2022-2027)
10.2.4.3. Columbia BCG Vaccine Market Forecast (2022-2027)
10.2.4.4. Rest of South America BCG Vaccine Market Forecast (2022-2027)
10.2.5. Middle East and Africa BCG Vaccine Market Forecast (2022-2027)
10.2.5.1. Saudi Arabia BCG Vaccine Market Forecast (2022-2027)
10.2.5.2. United Arab Emirates BCG Vaccine Market Forecast (2022-2027)
10.2.5.3. Egypt BCG Vaccine Market Forecast (2022-2027)
10.2.5.4. Nigeria BCG Vaccine Market Forecast (2022-2027)
10.2.5.5. South Africa BCG Vaccine Market Forecast (2022-2027)
10.2.5.6. Turkey BCG Vaccine Market Forecast (2022-2027)
10.2.5.7. Rest of Middle East and Africa BCG Vaccine Market Forecast (2022-2027)
10.3. BCG Vaccine Market Forecast by Drug Type (2022-2027)
10.3.1. BCG Vaccine Forecast by Drug Type (2022-2027)
10.3.2. BCG Vaccine Market Share Forecast by Drug Type (2022-2027)
10.4. BCG Vaccine Market Forecast by Usage (2022-2027)
10.4.1. BCG Vaccine Forecast by Usage (2022-2027)
10.4.2. BCG Vaccine Market Share Forecast by Usage (2022-2027)
10.5. BCG Vaccine Market Forecast by Application (2022-2027)
10.5.1. BCG Vaccine Forecast by Application (2022-2027)
10.5.2. BCG Vaccine Market Share Forecast by Application (2022-2027)
11. List of Tables and Figures
Figure United States BCG Vaccine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada BCG Vaccine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico BCG Vaccine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany BCG Vaccine Revenue (Million USD) and Growth Rate (2017-2027)
Figure France BCG Vaccine Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK BCG Vaccine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia BCG Vaccine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy BCG Vaccine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe BCG Vaccine Revenue (Million USD) and Growth Rate (2017-2027)
Figure China BCG Vaccine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan BCG Vaccine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea BCG Vaccine Revenue (Million USD) and Growth Rate (2017-2027)
Figure India BCG Vaccine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia BCG Vaccine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific BCG Vaccine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil BCG Vaccine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina BCG Vaccine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia BCG Vaccine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America BCG Vaccine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia BCG Vaccine Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates BCG Vaccine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt BCG Vaccine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria BCG Vaccine Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa BCG Vaccine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey BCG Vaccine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa BCG Vaccine Revenue (Million USD) and Growth Rate (2017-2027)
Table Global BCG Vaccine Revenue and Revenue Share by Drug Type (2017-2021)
Figure Global Immune BCG Revenue and Growth Rate (2017-2021)
Figure Global Therapy BCG Revenue and Growth Rate (2017-2021)
Table Global BCG Vaccine Revenue and Revenue Share by Usage (2017-2021)
Figure Global Tuberculosis Revenue and Growth Rate (2017-2021)
Figure Global Bladder Cancer Revenue and Growth Rate (2017-2021)
Table Global BCG Vaccine Revenue and Revenue Share by Application (2017-2021)
Figure Global Clinics Revenue and Growth Rate (2017-2021)
Figure Global Hospitals Revenue and Growth Rate (2017-2021)
Figure Global Others Revenue and Growth Rate (2017-2021)
Table Global BCG Vaccine Revenue by Regions (2017-2021)
Figure North America BCG Vaccine Growth Rate (2017-2021)
Figure North America BCG Vaccine Revenue and Growth Rate (2017-2021)
Figure North America BCG Vaccine by Countries (2017-2021)
Figure North America BCG Vaccine Revenue (Million USD) by Countries (2017-2021)
Figure United States BCG Vaccine Growth Rate (2017-2021)
Figure United States BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Canada BCG Vaccine Growth Rate (2017-2021)
Figure Canada BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Mexico BCG Vaccine Growth Rate (2017-2021)
Figure Mexico BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Europe BCG Vaccine Growth Rate (2017-2021)
Figure Europe BCG Vaccine Revenue and Growth Rate (2017-2021)
Figure Europe BCG Vaccine by Countries (2017-2021)
Figure Europe BCG Vaccine Revenue (Million USD) by Countries (2017-2021)
Figure Germany BCG Vaccine Growth Rate (2017-2021)
Figure Germany BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
Figure France BCG Vaccine Growth Rate (2017-2021)
Figure France BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
Figure UK BCG Vaccine Growth Rate (2017-2021)
Figure UK BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Russia BCG Vaccine Growth Rate (2017-2021)
Figure Russia BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Italy BCG Vaccine Growth Rate (2017-2021)
Figure Italy BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Rest of Europe BCG Vaccine Growth Rate (2017-2021)
Figure Rest of Europe BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Asia-Pacific BCG Vaccine Growth Rate (2017-2021)
Figure Asia-Pacific BCG Vaccine Revenue and Growth Rate (2017-2021)
Figure Asia-Pacific BCG Vaccine by Countries (2017-2021)
Figure Asia-Pacific BCG Vaccine Revenue (Million USD) by Countries (2017-2021)
Figure China BCG Vaccine Growth Rate (2017-2021)
Figure China BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Japan BCG Vaccine Growth Rate (2017-2021)
Figure Japan BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Korea BCG Vaccine Growth Rate (2017-2021)
Figure Korea BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
Figure India BCG Vaccine Growth Rate (2017-2021)
Figure India BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Southeast Asia BCG Vaccine Growth Rate (2017-2021)
Figure Southeast Asia BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Rest of Asia-Pacific BCG Vaccine Growth Rate (2017-2021)
Figure Rest of Asia-Pacific BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
Figure South America BCG Vaccine Growth Rate (2017-2021)
Figure South America BCG Vaccine Revenue and Growth Rate (2017-2021)
Figure South America BCG Vaccine by Countries (2017-2021)
Figure South America BCG Vaccine Revenue (Million USD) by Countries (2017-2021)
Figure Brazil BCG Vaccine Growth Rate (2017-2021)
Figure Brazil BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Argentina BCG Vaccine Growth Rate (2017-2021)
Figure Argentina BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Columbia BCG Vaccine Growth Rate (2017-2021)
Figure Columbia BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Rest of South America BCG Vaccine Growth Rate (2017-2021)
Figure Rest of South America BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Middle East and Africa BCG Vaccine Growth Rate (2017-2021)
Figure Middle East and Africa BCG Vaccine Revenue and Growth Rate (2017-2021)
Figure Middle East and Africa BCG Vaccine by Countries (2017-2021)
Figure Middle East and Africa BCG Vaccine Revenue (Million USD) by Countries (2017-2021)
Figure Saudi Arabia BCG Vaccine Growth Rate (2017-2021)
Figure Saudi Arabia BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
Figure United Arab Emirates BCG Vaccine Growth Rate (2017-2021)
Figure United Arab Emirates BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Egypt BCG Vaccine Growth Rate (2017-2021)
Figure Egypt BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Nigeria BCG Vaccine Growth Rate (2017-2021)
Figure Nigeria BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
Figure South Africa BCG Vaccine Growth Rate (2017-2021)
Figure South Africa BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Turkey BCG Vaccine Growth Rate (2017-2021)
Figure Turkey BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Rest of Middle East and Africa BCG Vaccine Growth Rate (2017-2021)
Figure Rest of Middle East and Africa BCG Vaccine Revenue (Millions USD) and Growth Rate (2017-2021)
Table Microgen BCG Vaccine Financial Overview
Table InterVax Ltd BCG Vaccine Financial Overview
Table Merck Sharp & Dohme Corp. BCG Vaccine Financial Overview
Table Green Signal Bio Pharma Private Limited BCG Vaccine Financial Overview
Table Japan BCG Laboratory BCG Vaccine Financial Overview
Table Serum Institute of India Pvt Ltd BCG Vaccine Financial Overview
Table AJ Vaccines BCG Vaccine Financial Overview
Table Biomed Lublin S.A. BCG Vaccine Financial Overview
Table Sanofi S.A. BCG Vaccine Financial Overview
Figure Global BCG Vaccine Revenue (Millions USD) and Growth Rate (2022-2027)
Table BCG Vaccine Market Forecast by Regions (2022-2027)
Figure North America BCG Vaccine Market Forecast (2022-2027)
Figure United States BCG Vaccine Market Forecast (2022-2027)
Figure Canada BCG Vaccine Market Forecast (2022-2027)
Figure Mexico BCG Vaccine Market Forecast (2022-2027)
Figure Europe BCG Vaccine Market Forecast (2022-2027)
Figure Germany BCG Vaccine Market Forecast (2022-2027)
Figure France BCG Vaccine Market Forecast (2022-2027)
Figure UK BCG Vaccine Market Forecast (2022-2027)
Figure Russia BCG Vaccine Market Forecast (2022-2027)
Figure Italy BCG Vaccine Market Forecast (2022-2027)
Figure Rest of Europe BCG Vaccine Market Forecast (2022-2027)
Figure Asia-Pacific BCG Vaccine Market Forecast (2022-2027)
Figure China BCG Vaccine Market Forecast (2022-2027)
Figure Japan BCG Vaccine Market Forecast (2022-2027)
Figure Korea BCG Vaccine Market Forecast (2022-2027)
Figure India BCG Vaccine Market Forecast (2022-2027)
Figure Southeast Asia BCG Vaccine Market Forecast (2022-2027)
Figure Rest of Asia-Pacific BCG Vaccine Market Forecast (2022-2027)
Figure South America BCG Vaccine Market Forecast (2022-2027)
Figure Brazil BCG Vaccine Market Forecast (2022-2027)
Figure Argentina BCG Vaccine Market Forecast (2022-2027)
Figure Columbia BCG Vaccine Market Forecast (2022-2027)
Figure Rest of South America BCG Vaccine Market Forecast (2022-2027)
Figure Middle East and Africa BCG Vaccine Market Forecast (2022-2027)
Figure Saudi Arabia BCG Vaccine Market Forecast (2022-2027)
Figure United Arab Emirates BCG Vaccine Market Forecast (2022-2027)
Figure Egypt BCG Vaccine Market Forecast (2022-2027)
Figure Nigeria BCG Vaccine Market Forecast (2022-2027)
Figure South Africa BCG Vaccine Market Forecast (2022-2027)
Figure Turkey BCG Vaccine Market Forecast (2022-2027)
Figure Rest of Middle East and Africa BCG Vaccine Market Forecast (2022-2027)
Figure Global BCG Vaccine Forecast by Drug Type (2022-2027)
Figure Global BCG Vaccine Market Share Forecast by Drug Type (2022-2027)
Figure Global BCG Vaccine Forecast by Drug Type (2022-2027)
Figure Global BCG Vaccine Forecast by Usage (2022-2027)
Figure Global BCG Vaccine Market Share Forecast by Usage (2022-2027)
Figure Global BCG Vaccine Forecast by Usage (2022-2027)
Figure Global BCG Vaccine Forecast by Application (2022-2027)
Figure Global BCG Vaccine Market Share Forecast by Application (2022-2027)
Figure Global BCG Vaccine Forecast by Application (2022-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|